PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
BMJ Publishing Group
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/b20bc5349766429ca47d7ba6932e2280 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:b20bc5349766429ca47d7ba6932e2280 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:b20bc5349766429ca47d7ba6932e22802021-11-24T22:30:05ZPD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine10.1136/jitc-2020-0021792051-1426https://doaj.org/article/b20bc5349766429ca47d7ba6932e22802021-10-01T00:00:00Zhttps://jitc.bmj.com/content/9/10/e002179.fullhttps://doaj.org/toc/2051-1426Mariaelena PierobonJohann De BonoRuth RiisnaesGiuseppe GiacconeMatthew BlackburnLance LiottaVienna LudoviniNeil J ShahGiuseppina ImprotaAntonella RavaggiNiven MehraAngelo SidoniElisa BaldelliK Alex HodgeGuido BellezzaGuido GambaraMartina MandaranoChamodya RuhunusiriBryant DunetzMaysa Abu-KhalafJulia WulfkuhleRosa I GallagherFranco OdicinoMaria Isabella SereniAngela ZupaPerry DemskoLucio Crino'Emanuel F PetricoinBMJ Publishing GrouparticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJournal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
| spellingShingle |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Mariaelena Pierobon Johann De Bono Ruth Riisnaes Giuseppe Giaccone Matthew Blackburn Lance Liotta Vienna Ludovini Neil J Shah Giuseppina Improta Antonella Ravaggi Niven Mehra Angelo Sidoni Elisa Baldelli K Alex Hodge Guido Bellezza Guido Gambara Martina Mandarano Chamodya Ruhunusiri Bryant Dunetz Maysa Abu-Khalaf Julia Wulfkuhle Rosa I Gallagher Franco Odicino Maria Isabella Sereni Angela Zupa Perry Demsko Lucio Crino' Emanuel F Petricoin PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine |
| format |
article |
| author |
Mariaelena Pierobon Johann De Bono Ruth Riisnaes Giuseppe Giaccone Matthew Blackburn Lance Liotta Vienna Ludovini Neil J Shah Giuseppina Improta Antonella Ravaggi Niven Mehra Angelo Sidoni Elisa Baldelli K Alex Hodge Guido Bellezza Guido Gambara Martina Mandarano Chamodya Ruhunusiri Bryant Dunetz Maysa Abu-Khalaf Julia Wulfkuhle Rosa I Gallagher Franco Odicino Maria Isabella Sereni Angela Zupa Perry Demsko Lucio Crino' Emanuel F Petricoin |
| author_facet |
Mariaelena Pierobon Johann De Bono Ruth Riisnaes Giuseppe Giaccone Matthew Blackburn Lance Liotta Vienna Ludovini Neil J Shah Giuseppina Improta Antonella Ravaggi Niven Mehra Angelo Sidoni Elisa Baldelli K Alex Hodge Guido Bellezza Guido Gambara Martina Mandarano Chamodya Ruhunusiri Bryant Dunetz Maysa Abu-Khalaf Julia Wulfkuhle Rosa I Gallagher Franco Odicino Maria Isabella Sereni Angela Zupa Perry Demsko Lucio Crino' Emanuel F Petricoin |
| author_sort |
Mariaelena Pierobon |
| title |
PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine |
| title_short |
PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine |
| title_full |
PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine |
| title_fullStr |
PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine |
| title_full_unstemmed |
PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine |
| title_sort |
pd-l1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine |
| publisher |
BMJ Publishing Group |
| publishDate |
2021 |
| url |
https://doaj.org/article/b20bc5349766429ca47d7ba6932e2280 |
| work_keys_str_mv |
AT mariaelenapierobon pdl1quantificationacrosstumortypesusingthereversephaseproteinmicroarrayimplicationsforprecisionmedicine AT johanndebono pdl1quantificationacrosstumortypesusingthereversephaseproteinmicroarrayimplicationsforprecisionmedicine AT ruthriisnaes pdl1quantificationacrosstumortypesusingthereversephaseproteinmicroarrayimplicationsforprecisionmedicine AT giuseppegiaccone pdl1quantificationacrosstumortypesusingthereversephaseproteinmicroarrayimplicationsforprecisionmedicine AT matthewblackburn pdl1quantificationacrosstumortypesusingthereversephaseproteinmicroarrayimplicationsforprecisionmedicine AT lanceliotta pdl1quantificationacrosstumortypesusingthereversephaseproteinmicroarrayimplicationsforprecisionmedicine AT viennaludovini pdl1quantificationacrosstumortypesusingthereversephaseproteinmicroarrayimplicationsforprecisionmedicine AT neiljshah pdl1quantificationacrosstumortypesusingthereversephaseproteinmicroarrayimplicationsforprecisionmedicine AT giuseppinaimprota pdl1quantificationacrosstumortypesusingthereversephaseproteinmicroarrayimplicationsforprecisionmedicine AT antonellaravaggi pdl1quantificationacrosstumortypesusingthereversephaseproteinmicroarrayimplicationsforprecisionmedicine AT nivenmehra pdl1quantificationacrosstumortypesusingthereversephaseproteinmicroarrayimplicationsforprecisionmedicine AT angelosidoni pdl1quantificationacrosstumortypesusingthereversephaseproteinmicroarrayimplicationsforprecisionmedicine AT elisabaldelli pdl1quantificationacrosstumortypesusingthereversephaseproteinmicroarrayimplicationsforprecisionmedicine AT kalexhodge pdl1quantificationacrosstumortypesusingthereversephaseproteinmicroarrayimplicationsforprecisionmedicine AT guidobellezza pdl1quantificationacrosstumortypesusingthereversephaseproteinmicroarrayimplicationsforprecisionmedicine AT guidogambara pdl1quantificationacrosstumortypesusingthereversephaseproteinmicroarrayimplicationsforprecisionmedicine AT martinamandarano pdl1quantificationacrosstumortypesusingthereversephaseproteinmicroarrayimplicationsforprecisionmedicine AT chamodyaruhunusiri pdl1quantificationacrosstumortypesusingthereversephaseproteinmicroarrayimplicationsforprecisionmedicine AT bryantdunetz pdl1quantificationacrosstumortypesusingthereversephaseproteinmicroarrayimplicationsforprecisionmedicine AT maysaabukhalaf pdl1quantificationacrosstumortypesusingthereversephaseproteinmicroarrayimplicationsforprecisionmedicine AT juliawulfkuhle pdl1quantificationacrosstumortypesusingthereversephaseproteinmicroarrayimplicationsforprecisionmedicine AT rosaigallagher pdl1quantificationacrosstumortypesusingthereversephaseproteinmicroarrayimplicationsforprecisionmedicine AT francoodicino pdl1quantificationacrosstumortypesusingthereversephaseproteinmicroarrayimplicationsforprecisionmedicine AT mariaisabellasereni pdl1quantificationacrosstumortypesusingthereversephaseproteinmicroarrayimplicationsforprecisionmedicine AT angelazupa pdl1quantificationacrosstumortypesusingthereversephaseproteinmicroarrayimplicationsforprecisionmedicine AT perrydemsko pdl1quantificationacrosstumortypesusingthereversephaseproteinmicroarrayimplicationsforprecisionmedicine AT luciocrino pdl1quantificationacrosstumortypesusingthereversephaseproteinmicroarrayimplicationsforprecisionmedicine AT emanuelfpetricoin pdl1quantificationacrosstumortypesusingthereversephaseproteinmicroarrayimplicationsforprecisionmedicine |
| _version_ |
1718414713618956288 |